Martin Louis Wilson - 18 Aug 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Signature
/s/ Martin Louis Wilson
Issuer symbol
RCKT
Transactions as of
18 Aug 2025
Net transactions value
-$4,839
Form type
4
Filing time
20 Aug 2025, 17:00:20 UTC
Previous filing
18 Aug 2025
Next filing
09 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wilson Martin General Counsel C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Louis Wilson 20 Aug 2025 0001704342

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $3,077 -1,004 -0.73% $3.06 136,050 18 Aug 2025 Direct F1, F2
transaction RCKT Common Stock Sale $1,762 -588 -0.43% $3.00 135,462 19 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.